CMVpp65 peptide vaccine (University of Heidelberg)
N/A
Report date: 2022/12/31 19:25:33
Base Information
Drug NameCMVpp65 peptide vaccine (University of Heidelberg)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Heidelberg
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of Heidelberg
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A